| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | SDI LIMITED: Removal from Official List | - | ASX | ||
| SDI LIMITED Aktie jetzt für 0€ handeln | |||||
| 06.07. | SDI LIMITED: Implementation of the Scheme | - | ASX | ||
| 25.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 25.06.2026 | 749 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 25.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 25.06.2026ISIN NameAU000000SDI2 SDI... ► Artikel lesen | |
| 25.06. | XFRA HQO: AUSSETZUNG/SUSPENSION | 238 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSDI LTD HQO AU000000SDI2... ► Artikel lesen | |
| 25.06. | SDI LIMITED: Suspension from Quotation | - | ASX | ||
| 25.06. | SDI Limited Scheme of Arrangement Becomes Effective, ASX Shares Suspended | 2 | Finance News Network | ||
| 25.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 25.06.2026 | 2.193 | Xetra Newsboard | Das Instrument 74F CA53184C1005 LIFE + BANC SPLIT EQUITY wird ex Kapitalmassnahme gehandelt am 25.06.2026 The instrument 74F CA53184C1005 LIFE + BANC SPLIT EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 25.06. | SDI LIMITED: Scheme becomes effective | - | ASX | ||
| 24.06. | Supreme Court Approves SDI Limited Scheme of Arrangement | 2 | Finance News Network | ||
| 24.06. | SDI LIMITED: Court Approves Scheme | - | ASX | ||
| 22.06. | SDI LIMITED: Results of Scheme Meeting | - | ASX | ||
| 22.06. | SDI Limited Shareholders Advance A$1.40 Per Share Acquisition Scheme | 1 | Finance News Network | ||
| 22.06. | SDI LIMITED: Chair's Address to Shareholders | - | ASX | ||
| 17.06. | SDI LIMITED: Update on Scheme Conditions | - | ASX | ||
| 17.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 17.06.2026 | 557 | Xetra Newsboard | The following instruments on XETRA do have their first trading 17.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 17.06.2026
Aktien
1 CNE100006Z46 Unisound AI Technology... ► Artikel lesen | |
| 16.06. | SDI LIMITED: Notice of Second Court Hearing | - | ASX | ||
| 22.05. | SDI LIMITED: Dispatch of Scheme Booklet | - | ASX | ||
| 21.05. | SDI LIMITED: Scheme Booklet amended lodgment header 2 | - | ASX | ||
| 19.05. | SDI LIMITED: Scheme Booklet amended lodgment header | - | ASX | ||
| 18.05. | SDI LIMITED: Scheme approved by ASIC & Court | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | +0,08 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 25,650 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,370 | +0,57 % | ROUNDUP/Aktien Frankfurt Schluss: Verlustserie beendet - Dax über 26.000 Punkten | FRANKFURT (dpa-AFX) - Der Dax hat sich am Freitag nach einer viertägigen Verlustserie etwas erholt. Nach Anlaufschwierigkeiten schaffte es der deutsche Leitindex wieder über die psychologisch wichtige... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SIEMENS HEALTHINEERS | 40,450 | +0,62 % | DAX-Check LIVE: Aixtron, Commerzbank, Siemens Healthineers, Volkswagen, Vonvoia im Fokus | Der DAX hat sich zum Wochenschluss erholt und den Handel nach vier Verlusttagen in Folge mit einem Plus beendet. Der deutsche Leitindex schloss in Frankfurt bei 26.137 Punkten und damit rund 0,6 Prozent... ► Artikel lesen | |
| FRESENIUS | 46,330 | -0,58 % | Fresenius verkauft FMC-Paket - das müssen Anleger wissen | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,670 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BETA BIONICS | 19,040 | 0,00 % | Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics |